FDA expands use of Teva’s Austedo in Parkinson’s

31st August 2017 Uncategorised 0

Teva’s Austedo is now the first and only therapy approved in the US to treat both tardive dyskinesia and chorea associated with Huntington’s disease.

More: FDA expands use of Teva’s Austedo in Parkinson’s
Source: News